The Pentagon Is Stockpiling and This Company Is Poised With a "Tier 1 Priority" Resource

America is racing to rebuild its domestic supply of strategic materials. One company with projects across key allied nations is in the right place at the right time.

GSK Plc ADR
NYSE:GSK
$36.17
Open 37.95 Prev Close 38.28
High 38.24 Low 35.46
Volume 12,333,123 Volume (Avg) 5,223
52 Week High 43.19 52 Week Low 31.01
Market Cap 73.1B PE Ratio 18.78

General

NameGSK Plc ADR
TickerGSK
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees68,629

About GSK Plc ADR

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.

Highlights

Analyst Target44.59
Market Cap73,107,900,000
PE Ratio18.78
PEG Ratio0.38
EBITDA8,654,000,128

Valuation

Trailing PE18.67
Forward PE8.63
Price/Sales (Trailing 12 Mt.)2.49
Price/Book (Most Recent Quarter)4.04

Technicals

Beta0.51
52 Week High43.19
52 Week Low31.01
50 Day Average-7.02%
200 Day Average-2.37%

Dividend

GSK Plc ADR pays out a dividend of $1.77 per share, with a dividend yield of 4.89%.

GSK's last dividend payment was made to shareholders on July 10, 2025.

They pay out 94.89% of their earnings out as a dividend.

Recent Dividends

Jul 10, 2025$0.43
Apr 10, 2025$0.41
Jan 9, 2025$0.39
Oct 10, 2024$0.39
Jul 11, 2024$0.38
Apr 11, 2024$0.40
Jan 11, 2024$0.34
Oct 12, 2023$0.36
Most Popular

Semiconductor Stocks React To Key Policies And Earnings

Semiconductor chip companies, including Nvidia, AMD, Broadcom, Marvell Tech, and Super Micro had a volatile week due to trade policies and earnings.

Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.

Robotics Valuation Gap: Who Will Win? - Ad

Two companies. Same sector. Vastly different valuations. One brings in millions in revenue, the other, barely a fraction. The market hasn't caught on yet.

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Do as I say, not as I do: On my failings as an investor

If a knowledgeable observer trained his or her sights on my choices, what are the trouble spots they would identify? Here are some of the biggies.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

After Diddy's conviction, here's where his business ventures stand

LOS ANGELES (AP) — Sean “Diddy” Combs has been in his federal sex trafficking trial, but that doesn't mean the once-celebrated music mogul will see his business empire restored.

ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday

ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a jump to 39.8 million shares from an average of 1.12 million.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Once Powerless, Now Priceless: V.J. Edgecombe's Journey From No Electricity to $50.4M NBA Future

Valdez "V.J." Edgecombe Jr., a young basketball player who once lived without electricity for seven years, is now on the verge of signing a contract worth $50.4 million.

OpenAI's Sam Altman Hints At Compensation Evaluation Amid Meta's 'Distasteful' AI Talent Poaching Spree: Report

OpenAI CEO Sam Altman in a message to OpenAI researchers, reportedly emphasized the importance of staying with OpenAI and hinted at possible compensation evaluations.

Leaked: Jobs' Final Apple Project Exposed - Ad

Bloomberg just leaked details of a secret project Steve Jobs set in motion before his death. After more than a decade under wraps, Apple is finally preparing to unleash this breakthrough - one that could reshape a $9 trillion industry overnight.

Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .

Elon Musk Renews Demand for Jeffrey Epstein Files Release, Weeks After Alleging Trump Is Named in Them

Elon Musk has once again demanded the release of the unredacted Jeffrey Epstein files. This comes in the wake of his allegations against President Trump.

Copper's Spiking - And This Junior Has the Grades to Match - Ad

Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.

Lisa Murkowski Defends Alaska Carveouts As Elizabeth Warren, Bernie Sanders And Rand Paul Condemn Trump's 'Big Beautiful' Bill: 'Not Good Enough For The Rest Of Our Nation'

Senators across party lines are fiercely divided over Donald Trump's $3.3 trillion "Big Beautiful Bill," which narrowly passed the Senate and now heads to the House amid concerns over debt, tax cuts, and social program rollbacks.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

Trump asks Supreme Court to remove 3 Democrats on the Consumer Product Safety Commission

WASHINGTON (AP) — The Trump administration on Wednesday asked the to remove three Democratic members of the , who were fired by President and then reinstated by a federal judge.

650% Later, Rocket Lab CEO Isn't One Bit Worried

Rocket Lab CEO Peter Beck highlights strong demand for launches from both commercial and government customers.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

North Koreans swim and play at a beach resort touted as a boost for tourism

SEOUL, South Korea (AP) — North Koreans swam, rode water park slides and enjoyed other water activities at a newly opened state media reported Wednesday, as the country largely maintains a ban on the entry of foreign tourists.

Datadog Stock Surges On S&P 500 Inclusion

Datadog Inc (NASDAQ:DDOG) shares are trading higher in Wednesday's after-hours session after it was announced that the company will join the S&P 500.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Gen Z Loves Job-Hopping, But This Boss Who Stayed In The Same Company For 35 Says There's An Upside To Staying Put

CEO Janet Godwin says best advice was to focus on current job, not next promotion. Gen Z prioritizes flexibility, while job hopping can lead to higher earnings but also impact retirement savings.

Here's Why 'Altcoin Season' For XRP, ETH, SOL Has Not Happened Yet

Cryptocurrency analyst Benjamin Cowen has argued that an ‘altcoin season‘ has failed to materialize due to monetary policy, liquidity and stubborn Bitcoin (CRYPTO:

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Iran resumes international flights after a 20-day suspension

TEHRAN, Iran (AP) — Iran’s Imam Khomeini International Airport has welcomed its first foreign flight since the resumption of international air travel after a 20-day suspension, local media reported Friday.

The Pentagon Is Stockpiling and This Company Is Poised With a "Tier 1 Priority" Resource - Ad

America is racing to rebuild its domestic supply of strategic materials. One company with projects across key allied nations is in the right place at the right time.

Once known as 'Dirty Myrtle,' Myrtle Beach is now the fastest-growing US metro for seniors

A South Carolina beach town once nicknamed “Dirty Myrtle” because of its rowdy nightclubs and strip joints has become a magnet for retirees in a nation that continues to age.

Robotics Valuation Gap: Who Will Win? - Ad

Two companies. Same sector. Vastly different valuations. One brings in millions in revenue, the other, barely a fraction. The market hasn't caught on yet.

Nike Beats The Street And Says The Worst Is Over

Nike Inc (NKE) stock rallies after upbeat fiscal Q4 results. Analysts maintain Buy ratings, raise price targets, citing potential for growth.

Bitcoin Gets 'Bigger' The More Money Central Banks Print, Says Popular Crypto Analyst: 'It's A Beautiful Thing'

Bitcoin (CRYPTO: BTC) purist Willy Woo tied the leading cryptocurrency’s growth with global liquidity on Wednesday, stating that the more money printed, the larger it will become.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Supreme Court upholds Texas law aimed at blocking kids from seeing pornography online

WASHINGTON (AP) — on Friday upheld a Texas law aimed at blocking children under 18 from seeing online pornography.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Amy Coney Barrett Earns Trump's Credit After Court Ruling: 'I Have Great Respect For Her'

Trump praises Justice Barrett's Supreme Court ruling limiting nationwide injunctions, while blasting NYC's Mamdani and defending his economic agenda.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service